Karoly Kis-Orban

Targu-mures, MS 540136, Romania

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Clinical Outcomes and Predictors of Response to Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: A Retrospective Cohort Study over a 4-Year Period.

Clinical Outcomes and Predictors of Response to Levodopa-Entacapone-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: A Retrospective Cohort Study over a 4-Year Period.

Journal: Pharmaceutics

Published: March 13, 2026

Applicability and feasibility of the updated ILAE seizure classification in secondary referral centers.

Applicability and feasibility of the updated ILAE seizure classification in secondary referral centers.

Journal: Epilepsia

Published: November 04, 2025

Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain-Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam.

Distribution of NECAB1-Positive Neurons in Normal and Epileptic Brain-Expression Changes in Temporal Lobe Epilepsy and Modulation by Levetiracetam and Brivaracetam.

Journal: International journal of molecular sciences

Published: April 07, 2025

Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease.

Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer's Disease.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 09, 2025

Marked differences in the effects of levetiracetam and its analogue brivaracetam on microglial, astrocytic, and neuronal density in the rat model of kainic acid-induced temporal lobe epilepsy.

Marked differences in the effects of levetiracetam and its analogue brivaracetam on microglial, astrocytic, and neuronal density in the rat model of kainic acid-induced temporal lobe epilepsy.

Journal: Frontiers in pharmacology

Published: December 30, 2024

Two years' experience with levodopa-entacapone-carbidopa intestinal gel treatment in advanced Parkinson's disease

Two years' experience with levodopa-entacapone-carbidopa intestinal gel treatment in advanced Parkinson's disease

Journal: Orvosi hetilap

Published: October 11, 2024

Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience.

Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience.

Journal: Pharmaceutics

Published: January 19, 2024

Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients.

Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients.

Journal: Scientific reports

Published: October 09, 2023

Importance of personality disorders in epilepsy

Importance of personality disorders in epilepsy

Journal: Ideggyogyaszati szemle

Published: October 02, 2023

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Observations and Dilemmas after 10 Years of Real-Life Experience.

Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Observations and Dilemmas after 10 Years of Real-Life Experience.

Journal: Pharmaceutics

Published: April 14, 2022

Ten-year trends of the characteristics in patients with advanced Parkinson's disease at the time of intestinal gel therapy introduction

Ten-year trends of the characteristics in patients with advanced Parkinson's disease at the time of intestinal gel therapy introduction

Journal: Orvosi hetilap

Published: March 17, 2022

Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease.

Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease.

Journal: Brain sciences

Published: May 26, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026